ahlam1399
03-21-2016, 04:05 PM
BRIEF-Onco**va enrolls first patient in Europe for Phase 3 trial of rigosertib
* Enrolls first patient in Europe for Phase 3 Inspire trialof rigosertib in higher-risk myelodysplastic syndromeshttp://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=GinkkyQy1oc:l4q8fBgZY5A:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=GinkkyQy1oc:l4q8fBgZY5A:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=GinkkyQy1oc:l4q8fBgZY5A:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=GinkkyQy1oc:l4q8fBgZY5A:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=GinkkyQy1oc:l4q8fBgZY5A:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/GinkkyQy1oc
* Enrolls first patient in Europe for Phase 3 Inspire trialof rigosertib in higher-risk myelodysplastic syndromeshttp://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=GinkkyQy1oc:l4q8fBgZY5A:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=GinkkyQy1oc:l4q8fBgZY5A:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=GinkkyQy1oc:l4q8fBgZY5A:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=GinkkyQy1oc:l4q8fBgZY5A:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=GinkkyQy1oc:l4q8fBgZY5A:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/GinkkyQy1oc